WOLTERS KLUWER NV/ NL0000395903 /
31.05.2024 9:05:05 | Изменение -2.45 | Объем сделки | Бид17:30:00 | Предложение17:30:00 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
146.00EUR | -1.65% | 0 Оборот: - |
-Величина цены спроса: - | -Величина цены предложения: - | 35.13 млрдEUR | 1.42% | 35.54 |
GlobeNewswire
23:07
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
18:30
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
17:31
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
16:55
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
16:00
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
16:00
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
16:00
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
15:51
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
15:01
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
14:56
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
14:52
NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autono...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница